Skip to Content

SUNDAY, 30 APRIL 2017, 07:07


FDA approves Radius Health’s osteoporosis drug Tymlos

Yesterday at 00:57 AM, via Reuters

(Reuters) – The U.S. Food and Drug Administration on Friday approved Radius Health Inc’s drug to treat osteoporosis in postmenopausal women at high risk of fracture or those who have failed other therapies.

Mexican Congress approves use of medical marijuana

Friday at 23:36 PM, via Reuters

MEXICO CITY (Reuters) – Mexico’s Lower House of Congress passed a bill on Friday to legalize the use of marijuana and cannabis for medical and scientific needs, a step closer to outright legalization in a country long scarred by warring drug cartels.

A sleep class for tired parents

Friday at 22:26 PM, via CNN

A gym in London has started a new concept called ‘Napercise,’ a 60-minute sleep class to relax the body and mind.

US yellow fever vaccine supply will run out this summer

Friday at 21:44 PM, via CNN

American supplies of yellow fever vaccine are expected to run out this summer , the Centers for Disease Control and Prevention said Friday, and it released a report outlining a plan to ensure continuous access.

With Obamacare in doubt, California asks insurers to double up on rate filings

Friday at 21:44 PM, via Reuters

NEW YORK (Reuters) – Health insurers seeking regulatory approval for 2018 individual insurance plans can file two sets of premium rates as a way to deal with market uncertainty created by Republicans’ promise to repeal and replace Obamacare, a California state insurance regulator said on Friday.

Doctors should consider whether older patients can hear them

Friday at 20:31 PM, via Reuters

(Reuters Health) – Elderly people with hearing loss may have difficulty understanding speech in noisy healthcare settings – and the situation isn’t helped when doctors speak fast and use medical jargon, experts say.

Home blood pressure monitors may not be accurate enough

Friday at 16:46 PM, via Reuters

(Reuters Health) – Even as doctors are increasingly relying on home blood pressure monitoring to manage patients with hypertension, many of the devices are too inaccurate to be useful, according to a small study.

FDA approves Novartis’ leukemia treatment

Friday at 16:41 PM, via Reuters

(Reuters) – The U.S. Food and Drug Administration approved Novartis AG’s Rydapt as an initial treatment for acute myeloid leukemia (AML) as well as certain other blood disorders, the agency said on Friday.

‘Being deaf has shaped who I am’

Friday at 15:18 PM, via Health24

Aidan Whitehead was born profoundly deaf. At the age of two he received cochlear implants. This is his story.

Global med-tech firms, India locked in tussle after stent price sting

Friday at 15:03 PM, via Reuters

NEW DELHI/MUMBAI (Reuters) – A group of global medical-technology companies plans to tell Indian officials next month that any further price control measures would risk future investments and make them less likely to introduce new products in the country, according to an industry source familiar with the matter. The lobbying effort by Abbott Laboratories, Boston Scientific, Johnson & Johnson...

  1. Pages:
  2. 1
  3. 2
  4. 3
  5. 4
  6. 5
  7. ...
  8. 15